tiprankstipranks
Adaptimmune Therapeutics (ADAP)
NASDAQ:ADAP
Holding ADAP?
Track your performance easily

Adaptimmune Therapeutics (ADAP) Ownership - Who Owns Adaptimmune Therapeutics?

812 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
102,478,668Insider40.05%71,427,632
37,681,515Institution14.73%26,264,016
19,500,000Insider7.62%13,591,500
2,343,695Institution0.92%1,633,555
1,800,000Insider0.70%1,254,600
394,367Institution0.15%274,874
172,793Institution0.07%120,437
139,801Institution0.05%97,441
130,764Insider0.05%91,143
99,822Institution0.04%69,576

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
139,801Institution0.05%97,441
99,822Institution0.04%69,576
16,257Institution<0.01%11,331
6,385Institution<0.01%4,450
554Institution<0.01%386

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
247,468Institution0.10%163,725
174,485Institution0.07%115,439
146,899Institution0.06%97,188
34,809Institution0.01%24,265
6Institution<0.01%4

FAQ

Who Owns Adaptimmune Therapeutics (ADAP)?
Currently, no data Available
What percentage of Adaptimmune Therapeutics (ADAP) stock is held by institutional investors?
Currently, no data Available
What percentage of Adaptimmune Therapeutics (ADAP) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Adaptimmune Therapeutics (ADAP)?
David Mott owns the most shares of Adaptimmune Therapeutics (ADAP).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis